Abiopharma

SLR Investment Corp. Announces Quarter Ended March 31, 2026 Financial Results

Credit Acceptance Announces Completion Of $450.0 Million Asset-Backed Financing

Avalyn to Present Patient-Centered Research on AP01 Delivery and Supportive Care Experiences at American Thoracic Society 2026 International Conference

Versigent Reports First Quarter 2026 Results

Ultragenyx Reports First Quarter 2026 Financial Results and Corporate Update

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 2026 Financial Results

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GLOB Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Globant S.A. Securities Lawsuit - Contact Levi & Korsinsky

INmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases

Gulfport Energy Reports First Quarter 2026 Financial and Operational Results